Lynne Sullivan
2020
In 2020, Lynne Sullivan earned a total compensation of $2.9M as Chief Financial Officer and Head of Corporate Development at Unity Biotechnology.
Compensation breakdown
| Non-Equity Incentive Plan | $66,696 |
|---|---|
| Option Awards | $1,912,392 |
| Salary | $166,667 |
| Stock Awards | $705,600 |
| Other | $4,667 |
| Total | $2,856,022 |
Sullivan received $1.9M in option awards, accounting for 67% of the total pay in 2020.
Sullivan also received $66.7K in non-equity incentive plan, $166.7K in salary, $705.6K in stock awards and $4.7K in other compensation.
Rankings
In 2020, Lynne Sullivan's compensation ranked 4,048th out of 13,090 executives tracked by ExecPay. In other words, Sullivan earned more than 69.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,048 out of 13,090 | 69th |
Division Manufacturing | 1,633 out of 5,620 | 71st |
Major group Chemicals And Allied Products | 626 out of 2,253 | 72nd |
Industry group Drugs | 538 out of 1,953 | 73rd |
Industry Pharmaceutical Preparations | 411 out of 1,458 | 72nd |
Source: SEC filing on April 30, 2021.
Sullivan's colleagues
We found three more compensation records of executives who worked with Lynne Sullivan at Unity Biotechnology in 2020.